Viatris (VTRS (NASDAQ)), the global healthcare company VTRS., has named Theodora Mistras as its incoming Chief Financial Officer, effective from March 1. Additionally, Viatris appointed Philippe Martin as its new Chief Research and Development Officer, effective immediately.
The current CFO, Sanjeev Narula, will collaborate closely with Mistras to facilitate a seamless transition and will subsequently exit the company on March 1.
Mistras, previously the managing director of healthcare investment banking at Citigroup Global Markets, brings nearly two decades of leadership, advisory, and capital markets expertise to Viatris, the company noted.
In October, Viatris disclosed its plans to divest certain businesses, totaling up to $3.6 billion, as part of its long-term strategy to concentrate on three core therapeutic areas: ophthalmology, gastroenterology, and dermatology.
Have you read?
The world’s top 50 most popular luxury brands for 2023.
Richest Tennis Players In The World.
Richest Actors In The World.
The World’s Richest People (Top Billionaires, 2023).
Revealed: Countries With The Best Health Care Systems, 2023.
Top Most Valuable Coins For Collectors Across The Globe.
Add CEOWORLD magazine to your Google News feed.
Follow CEOWORLD magazine headlines on: Google News, LinkedIn, Twitter, and Facebook.
Copyright 2024 The CEOWORLD magazine. All rights reserved. This material (and any extract from it) must not be copied, redistributed or placed on any website, without CEOWORLD magazine' prior written consent. For media queries, please contact: info@ceoworld.biz
